(Q45295711)

11 December 2017

title

Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's disease (English)

1 reference

11 December 2017

0 references

2

1 reference

11 December 2017

Messmer K

1

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

11 December 2017

1 reference

11 December 2017

volume

241

1 reference

11 December 2017

issue

1

1 reference

11 December 2017

page(s)

53-56

1 reference

Increase in diazepam binding inhibitor-like immunoreactivity (51-70) in Huntington's disease

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

The quantification of brain lesions with an omega 3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Increase inω3 (peripheral type benzodiazepine) binding sites in the rat cortex and striatum after local injection of interleukin-1, tumour necrosis factor-α and lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Peripheral benzodiazepine receptor modulation with phagocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Diazepam binding inhibitor (DBI): a peptide with multiple biological actions

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Peripheral type benzodiazepine binding sites following transient forebrain ischemia in the rat: effect of neuroprotective drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Peripheral benzodiazepine binding sites in Alzheimer's disease frontal and temporal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Imaging of primary and remote ischaemic and excitotoxic brain lesions. An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Human microglia convert l-tryptophan into the neurotoxin quinolinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Immuno-electron microscopic localization of immunoglobulins in amyloid fibrils of senile plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Morphometric studies of the neuropathological changes in choreatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Cortical peptide changes in Huntington's disease may be independent of striatal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Neocortical neurotransmitter markers in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Brain quinolinic acid in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Inflammation and Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

[3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Huntington's disease: Changes in striatal proteins reflect astrocytic gliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Remote microglial activation in the quinolinic acid model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Neuropathological classification of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

Multiple forms and locations for the peripheral-type benzodiazepine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900967-1

7 January 2021

10.1016/S0304-3940(97)00967-1

Identifiers

DOI

1 reference

11 December 2017

1 reference